Vident Advisory LLC purchased a new stake in Envista Holdings Corporation (NYSE:NVST - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 25,728 shares of the company's stock, valued at approximately $444,000.
Several other large investors have also recently bought and sold shares of the company. Magnetar Financial LLC bought a new position in Envista in the 1st quarter valued at $1,151,000. State of Wyoming boosted its holdings in Envista by 121.1% in the 1st quarter. State of Wyoming now owns 16,911 shares of the company's stock valued at $292,000 after purchasing an additional 9,264 shares during the period. Trexquant Investment LP boosted its holdings in Envista by 243.7% in the 1st quarter. Trexquant Investment LP now owns 1,065,849 shares of the company's stock valued at $18,397,000 after purchasing an additional 755,725 shares during the period. Ieq Capital LLC bought a new position in Envista in the 1st quarter valued at $752,000. Finally, Jump Financial LLC bought a new position in Envista in the 1st quarter valued at $1,107,000.
Wall Street Analysts Forecast Growth
Several research analysts have commented on NVST shares. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a report on Tuesday, May 27th. Mizuho upped their target price on shares of Envista from $15.00 to $18.00 and gave the stock an "underperform" rating in a research report on Friday, August 1st. Wall Street Zen downgraded Envista from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 30th. Evercore ISI raised their price target on Envista from $19.00 to $23.00 and gave the company an "outperform" rating in a research report on Wednesday, July 9th. Finally, Wells Fargo & Company raised their price target on Envista from $17.00 to $19.00 and gave the company an "equal weight" rating in a research report on Friday, August 1st. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $20.92.
Check Out Our Latest Analysis on Envista
Envista Trading Down 2.6%
NYSE:NVST traded down $0.56 during trading hours on Friday, reaching $21.05. The company's stock had a trading volume of 1,223,509 shares, compared to its average volume of 1,488,205. The firm has a market capitalization of $3.50 billion, a price-to-earnings ratio of 65.77, a PEG ratio of 1.16 and a beta of 0.99. The firm has a 50-day simple moving average of $20.54 and a 200-day simple moving average of $18.58. Envista Holdings Corporation has a 1 year low of $14.22 and a 1 year high of $23.00. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44.
Envista (NYSE:NVST - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. The company had revenue of $682.10 million for the quarter, compared to analysts' expectations of $638.21 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. The firm's revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the company earned $0.11 EPS. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. Research analysts expect that Envista Holdings Corporation will post 1 EPS for the current fiscal year.
Envista Company Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Articles

Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.